US FDA to discuss possible improvements to imaging equipment
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has scheduled a public meeting to identify possible improvements that can be made to computed tomography and fluoroscopic devices that would help reduce unnecessary patient exposure to ionisation radiation from these medical imaging modalities1.